|
Deepull deepull.com |
Deepull has developed UllCore BSI test, a high-plex PCR test targeting identification of 95% of sepsis-causing pathogens. Test, which is run over proprietary benchtop analyzer and disposables, works directly from whole blood, with no sample preparation required, and is able to detect hundreds of pathogens, including relevant antimicrobial resistance (AMR) genes, in about 60mins. Product got FDA Breakthrough Designation in Nov-24.
Jordi Carrera
CEO, Founder
Panakès board member
